Loading...
XNAS:RSLS
ReShape Lifesciences shares are trading higher after signing an exclusive distribution agreement with Recon Supply to access the VA and DoD markets, enhancing access to their weight loss and rehabilitation solutions.
ReShape Lifesciences shares are trading higher after receiving a Notice of Allowance for a U.S. patent on its Diabetes Neuromodulation technology, promising cost-effective and personalized diabetes management.